Mesa Laboratories
MLAB
Market cap $770M

141.70 USD

-4.20

2.88%

At close Feb 21, 4:00 PM EST

After hours

141.70

+0.00

0.00%

1 day

-2.88%

5 days

-3.59%

1 month

-3.37%

3 months

40.49%

6 months

8.13%

Year to date

7.37%

1 year

38.01%

5 years

-47.42%

10 years

89.74%

About: Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Employees: 736

Industrials Industrial Instruments for Measurement, Display, and Control

0

Funds holding %

of 7,139 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

14% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 51

6% more capital invested

Capital invested by funds: $635M [Q3] → $670M (+$35.6M) [Q4]

3.08% more ownership

Funds ownership: 90.6% [Q3] → 93.68% (+3.08%) [Q4]

6% less funds holding

Funds holding: 165 [Q3] → 155 (-10) [Q4]

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for MLAB.

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about MLAB published over the past 30 days

Zacks Investment Research

Why Mesa Labs (MLAB) Might be Well Poised for a Surge

Mesa Labs (MLAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Why Mesa Labs (MLAB) Might be Well Poised for a Surge

Zacks Investment Research

Mesa Labs (MLAB) Q3 Earnings and Revenues Beat Estimates

Mesa Labs (MLAB) came out with quarterly earnings of $2.67 per share, beating the Zacks Consensus Estimate of $2.45 per share. This compares to earnings of $2.02 per share a year ago.

Mesa Labs (MLAB) Q3 Earnings and Revenues Beat Estimates

Mesa Labs Announces Third Quarter Results

LAKEWOOD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q25”) ended December 31, 2024 (amounts in thousands).

Mesa Labs Announces Third Quarter Results

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025

LAKEWOOD, Colo., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2025 at approximately 8:00 A.M. Eastern time on Tuesday, February 4, 2025.

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025

MESA LABS DECLARES QUARTERLY DIVIDEND

LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 17, 2025, to shareholders of record at the close of business on February 28, 2025.

MESA LABS DECLARES QUARTERLY DIVIDEND

Zacks Investment Research

Mesa Labs (MLAB) Lags Q2 Earnings and Revenue Estimates

Mesa Labs (MLAB) came out with quarterly earnings of $2.45 per share, missing the Zacks Consensus Estimate of $2.48 per share. This compares to earnings of $1.91 per share a year ago.

Mesa Labs (MLAB) Lags Q2 Earnings and Revenue Estimates

Mesa Labs Announces Second Quarter Results

LAKEWOOD, Colo., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its second fiscal quarter (“2Q25”) ended September 30, 2024 (amounts in thousands).

Mesa Labs Announces Second Quarter Results

MESA LABS DECLARES QUARTERLY DIVIDEND

LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.

MESA LABS DECLARES QUARTERLY DIVIDEND

Zacks Investment Research

Surging Earnings Estimates Signal Upside for Mesa Labs (MLAB) Stock

Mesa Labs (MLAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Surging Earnings Estimates Signal Upside for Mesa Labs (MLAB) Stock

Zacks Investment Research

Mesa Labs (MLAB) Moves to Strong Buy: Rationale Behind the Upgrade

Mesa Labs (MLAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Mesa Labs (MLAB) Moves to Strong Buy: Rationale Behind the Upgrade

See News Rankings

Charts implemented using Lightweight Charts™